Cohen Veterans Bioscience Receives Research Award from Department of Defense’s Medical Research and Materiel Command to Establish A Clinical Trial Infrastructure and Conduct an Adaptive Platform Trial Testing Post-Traumatic Stress Disorder (PTSD) PharmacotherapeuticsOctober 4, 2018Read more
Cohen Veterans Bioscience will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year study to comparatively test pharmacotherapeutics for PTSD.
- September 6, 2018Read more
Early Signal subsidiary will expand CVB’s role as a hub for translational research and data analytics to fast-track solutions for brain disorders
- July 24, 2018Read more
The inaugural State of the Science Summit (SOSS) will focus on Diagnosis of Trauma-Related Brain Disorders and will be held in Silver Spring, Maryland on September 12-13, 2018.
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress DisorderJune 7, 2018Read more
Brainsway, a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience today announced the launch of a new research collaboration with the Stanford University School of Medicine to identify potential biomarkers in patients suffering from Post Traumatic Stress Disorder (PTSD).